San Francisco Sentry Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$62K Hold
604
0.03% 336
2021
Q1
$50K Buy
604
+235
+64% +$19.9K 0.02% 374
2020
Q4
$34K Hold
369
0.02% 402
2020
Q3
$30K Hold
369
0.02% 388
2020
Q2
$26K Buy
369
+195
+112% +$13.9K 0.01% 398
2020
Q1
$11K Sell
174
-621
-78% -$44.8K 0.01% 454
2019
Q4
$61K Hold
795
0.03% 350
2019
Q3
$58K Buy
795
+321
+68% +$22.5K 0.03% 352
2019
Q2
$29K Sell
474
-297
-39% -$18K 0.01% 435
2019
Q1
$49K Buy
771
+297
+63% +$16.9K 0.02% 392
2018
Q4
$24K Sell
474
-807
-63% -$40.8K 0.01% 453
2018
Q3
$74K Buy
1,281
+72
+6% +$3.52K 0.03% 354
2018
Q2
$59K Sell
1,209
-3
-0.2% -$140 0.02% 373
2018
Q1
$56K Buy
1,212
+99
+9% +$4.3K 0.02% 443
2017
Q4
$42K Buy
1,113
+300
+37% +$11K 0.01% 469
2017
Q3
$30K Sell
813
-261
-24% -$9.95K 0.01% 496
2017
Q2
$42K Buy
+1,074
New +$39.2K 0.02% 371
2013
Q3
Sell
-180
Closed -$2K 657
2013
Q2
$2K Buy
+180
New +$2.13K ﹤0.01% 618

Other funds holding EW

San Francisco Sentry Investment Group's EW Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Edwards Lifesciences (EW) position steady in Q2 2021 at 604 shares worth $62K. The position accounts for 0.03% of the portfolio, ranked #336.

San Francisco Sentry Investment Group first reported a position in EW in Q2 2013 and has held it in 18 quarters since. The position peaked at $74K in Q3 2018. 1,186 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • San Francisco Sentry Investment Group held 604 shares of Edwards Lifesciences worth $62K as of Q2 2021.
  • San Francisco Sentry Investment Group left its Edwards Lifesciences share count unchanged in Q2 2021.
  • Edwards Lifesciences made up 0.03% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #336 holding.
  • San Francisco Sentry Investment Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 18 quarters since.
  • San Francisco Sentry Investment Group's Edwards Lifesciences position peaked at $74K in Q3 2018.
  • 1,186 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.